{"nct_id":"NCT02915744","title":"A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine","status":"COMPLETED","status_verified_date":"2023-04","start_date":"2016-11","start_date_type":null,"primary_completion_date":"2020-07","primary_completion_date_type":"ACTUAL","completion_date":"2020-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NKTR"]}